Mundipharma
Rick Lones is a seasoned medical affairs professional with extensive leadership experience across various pharmaceutical companies. Currently serving as Vice President and Global Head of Medical Affairs at Mundipharma, Rick oversees a global team of over 90 professionals. Previous roles include Vice President of Medical Affairs at GW Pharmaceuticals and Intercept Pharmaceuticals, where Rick expanded international teams and developed strategies for the commercialization of innovative therapies. At Bristol-Myers Squibb, Rick significantly restructured the UK & Ireland Medical Affairs department while also contributing to a major European business restructure. An early career in the Royal Air Force as a Medical Officer, along with a solid educational foundation in medicine from the University of Southampton, has equipped Rick with a diverse skill set applicable to the pharmaceutical industry.
This person is not in any teams
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.